Table 57
Prevalence of hepatitis B surface antibody within the household population, by age and sex, Canada, 2007 to 2009
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
Prevalence of hepatitis B surface antibody | |||
---|---|---|---|
Estimate | Confidence interval | ||
From | To | ||
percent | |||
Both sexes | |||
Age 14 to 19 | 69.7 | 66.1 | 73.2 |
Age 20 to 39 | 40.6 | 35.0 | 46.2 |
Age 40 to 59 | 18.1 | 12.9 | 23.2 |
Age 60 to 79 | 12.5 | 9.2 | 15.8 |
Age 14 to 79 | 29.4 | 25.7 | 33.1 |
Males | |||
Age 14 to 19 | 72.7 | 68.1 | 77.3 |
Age 20 to 39 | 36.1 | 28.8 | 43.3 |
Age 40 to 59 | 14.7 E | 9.0 | 20.4 |
Age 60 to 79 | 10.9 E | 5.9 | 16.0 |
Age 14 to 79 | 26.8 | 22.3 | 31.3 |
Females | |||
Age 14 to 19 | 66.7 | 61.1 | 72.2 |
Age 20 to 39 | 45.3 | 38.3 | 52.4 |
Age 40 to 59 | 21.4 | 15.1 | 27.8 |
Age 60 to 79 | 13.9 | 10.1 | 17.7 |
Age 14 to 79 | 32.0 | 27.7 | 36.4 |
use with caution (data with a coefficient of variation (CV) from 16.6% to 33.3%)
Note(s):
Total household population aged 14 to 79, except those meeting the exclusion criteria (see the Canadian Health Measures Survey (CHMS) Data User Guide: Cycle 1).
Source(s):
Canadian Health Measures Survey, Cycle 1.
- Date modified: